Trial Profile
Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2015
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Lung injury
- Focus Therapeutic Use
- Sponsors Beijing Continent Pharmaceutical
- 27 Nov 2014 New trial record